Drug Delivery and Targeting

AvMonika Schäfer-Korting,Ulrich S. Schubert

Inbunden, Engelska, 2024

Del 284 i serien Handbook of Experimental Pharmacology

1 854 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

197 in 2010 there have been important advances in drug development, drug delivery and – more recently – drug targeting. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too.

Produktinformation

Utgivningsdatum:2024-03-30
Mått:155 x 235 x 27 mm
Vikt:876 g
Format:Inbunden
Språk:Engelska
Serie:Handbook of Experimental Pharmacology
Antal sidor:411
Förlag:Springer International Publishing AG
ISBN:9783031528637

Utforska kategorier

Farmakologi inom Medicin
Medicinsk utrustning och medicinska tekniker inom Medicin
Apotek och farmaceuter inom Medicin

Innehållsförteckning

Part I. Nanoparticles and other Advanced Technologies.- Knowledge-based design of multi-functional polymer-based nanoparticles.- Stimuli-responsive non-viral nanoparticles for gene delivery.- Sustainability in drug and nano-particle processing.- Advanced formulation approaches for proteins.- Microneedles and polymer films – delivery of peptides, proteins and nucleic acids.- Advances in vaccine delivery enhancers – small molecules and nanomaterials.- Biodegradable long acting injectables: Platform technology and industrial challenges.- Part II. Visualization Technologies.- Visualization of Nano-carriers and Drugs in Cells and Tissue.- Characterization of drug delivery systems by transmission electron microscopy.- Part III. Target Specific Delivery.- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders.- Interactions of nano-systems with immune cells and cancer cells – a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints.- New therapeutic options in pulmonal diseases – sphingolipids and sphingolipid metabolism.- Molecular therapeutics for pulmonary diseases – the need for drug targeting.- Delivery of mitochondrial RNA.- Part IV. Concerted Actions – Thinking the Drug from the Beginning.- ATMP formulations and delivery.- Preclinical testing and approval of ATMP.- Looking to the future – drug delivery in the prophylaxis and therapy of severe and chronic diseases.